Authors:
SCHNELL R
VITETTA E
SCHINDLER J
BARTH S
WINKLER U
BORCHMANN P
HANSMANN ML
DIEHL V
GHETIE V
ENGERT A
Citation: R. Schnell et al., CLINICAL-TRIALS WITH AN ANTI-CD25 RICIN A-CHAIN EXPERIMENTAL AND IMMUNOTOXIN (RFT5-SMPT-DGA) IN HODGKINS-LYMPHOMA, Leukemia & lymphoma, 30(5-6), 1998, pp. 525
Authors:
BORVAK J
RICHARDSON J
MEDESAN C
ANTOHE F
RADU C
SIMIONESCU M
GHETIE V
WARD ES
Citation: J. Borvak et al., FUNCTIONAL EXPRESSION OF THE MHC CLASS I-RELATED RECEPTOR, FCRN, IN ENDOTHELIAL-CELLS OF MICE, International immunology (Print), 10(9), 1998, pp. 1289-1298
Authors:
MEDESAN C
CIANGA P
MUMMERT M
STANESCU D
GHETIE V
WARD ES
Citation: C. Medesan et al., COMPARATIVE-STUDIES OF RAT IGG TO FURTHER DELINEATE THE FC-FCRN INTERACTION SITE, European Journal of Immunology, 28(7), 1998, pp. 2092-2100
Authors:
KAPLAN LD
ROBLES R
KAHN JO
SCHINDLER J
GHETIE V
VITETTA ES
Citation: Ld. Kaplan et al., PHASE-1 TRIAL OF ANTI-CD22 RICIN-A-CHAIN IMMUNOTOXIN (IGG-RFB4-DGA) FOR TREATMENT OF AIDS-LYMPHOMA, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 90-90
Citation: V. Ghetie et Es. Ward, FCRN - THE MHC CLASS I-RELATED RECEPTOR THAT IS MORE THAN AN IGG TRANSPORTER, Immunology today, 18(12), 1997, pp. 592-598
Authors:
MEDESAN C
MATESOI D
RADU C
GHETIE V
WARD ES
Citation: C. Medesan et al., DELINEATION OF THE AMINO-ACID-RESIDUES INVOLVED IN TRANSCYTOSIS AND CATABOLISM OF MOUSE IGG1, The Journal of immunology, 158(5), 1997, pp. 2211-2217
Authors:
SCHNELL R
VITETTA E
SCHINDLER J
BOHLEN H
HANSMANN ML
BARTH S
GHETIE V
UHR J
DIEHLL V
ENGERT A
Citation: R. Schnell et al., A CLINICAL-PHASE-I II TRIAL WITH AN ANTI-CD25 RICIN A-CHAIN IMMUNOTOXIN (RFT5-SMPT-DGA) IN PATIENTS WITH REFRACTORY HODGKINS LYMPHOMA/, Blood, 90(10), 1997, pp. 1517-1517
Authors:
ENGERT A
DIEHL V
SCHNELL R
RADSZUHN A
HATWIG MT
DRILLICH S
SCHON G
BOHLEN H
TESCH H
HANSMANN ML
BARTH S
SCHINDLER J
GHETIE V
UHR J
VITETTA E
Citation: A. Engert et al., A PHASE-I STUDY OF AN ANTI-CD25 RICIN A-CHAIN IMMUNOTOXIN (RFT5-SMPT-DGA) IN PATIENTS WITH REFRACTORY HODGKINS LYMPHOMA, Blood, 89(2), 1997, pp. 403-410
Authors:
SENDEROWICZ AM
VITETTA E
HEADLEE D
GHETIE V
UHR JW
FIGG WD
LUSH RM
STETLERSTEVENSON M
KERSHAW G
KINGMA DW
JAFFE ES
SAUSVILLE EA
Citation: Am. Senderowicz et al., COMPLETE SUSTAINED RESPONSE OF A REFRACTORY, POSTTRANSPLANTATION, LARGE B-CELL LYMPHOMA TO AN ANTI-CD22 IMMUNOTOXIN, Annals of internal medicine, 126(11), 1997, pp. 882-885
Authors:
BALUNA R
GHETIE V
OPPENHEIMERMARKS N
VITETTA ES
Citation: R. Baluna et al., FIBRONECTIN INHIBITS THE CYTOTOXIC EFFECT OF RICIN-A CHAIN ON ENDOTHELIAL-CELLS, International journal of immunopharmacology, 18(6-7), 1996, pp. 355-361
Authors:
POPOV S
HUBBARD JG
KIM JK
OBER B
GHETIE V
WARD ES
Citation: S. Popov et al., THE STOICHIOMETRY AND AFFINITY OF THE INTERACTION OF MURINE FC FRAGMENTS WITH THE MHC CLASS I-RELATED RECEPTOR, FCRN, Molecular immunology, 33(6), 1996, pp. 521-530
Authors:
GHETIE V
HUBBARD JG
KIM JK
TSEN MF
LEE YF
WARD ES
Citation: V. Ghetie et al., ABNORMALLY SHORT SERUM HALF-LIVES OF IGG IN BETA-2-MICROGLOBULIN-DEFICIENT MICE, European Journal of Immunology, 26(3), 1996, pp. 690-696
Citation: C. Medesan et al., LOCALIZATION OF THE SITE OF THE IGG MOLECULE THAT REGULATES MATERNOFETAL TRANSMISSION IN MICE, European Journal of Immunology, 26(10), 1996, pp. 2533-2536
Authors:
STONE MJ
SAUSVILLE EA
FAY JW
HEADLEE D
COLLINS RH
FIGG WD
STETLERSTEVENSON M
JAIN V
JAFFE ES
SOLOMON D
LUSH RM
SENDEROWICZ A
GHETIE V
SCHINDLER J
UHR JW
VITETTA ES
Citation: Mj. Stone et al., A PHASE-I STUDY OF BOLUS VERSUS CONTINUOUS-INFUSION OF THE ANTI-CD19 IMMUNOTOXIN, IGG-HD37-DGA, IN PATIENTS WITH B-CELL LYMPHOMA, Blood, 88(4), 1996, pp. 1188-1197
Authors:
CONRY RM
KHAZAELI MB
SALEH MN
GHETIE V
VITETTA ES
LIU TP
LOBUGLIO AF
Citation: Rm. Conry et al., PHASE-I TRIAL OF AN ANTI-CD19 DEGLYCOSYLATED RICIN-A CHAIN IMMUNOTOXIN IN NON-HODGKINS-LYMPHOMA - EFFECT OF AN INTENSIVE SCHEDULE OF ADMINISTRATION, Journal of immunotherapy with emphasis on tumor immunology, 18(4), 1995, pp. 231-241
Authors:
SCHNELL R
HATWIG MT
RADSZUHN A
CEBE F
DRILLICH S
SCHON G
BOHLEN H
HANSMANN ML
SCHINDLER J
GHETIE V
UHR J
DIEHL V
VITETTA ES
ENGERT A
Citation: R. Schnell et al., A CLINICAL-PHASE-I STUDY OF AN ANTI-CD25-DEGLYCOSYLATED RICIN A-CHAINIMMUNOTOXIN (RFT5-SMPT-DGA) IN PATIENTS WITH REFRACTORY HODGKINS-DISEASE, European journal of cancer, 31A, 1995, pp. 930-930
Citation: V. Ghetie et al., THE IN-VIVO ANTITUMOR-ACTIVITY OF IMMUNOTOXINS CONTAINING 2 VERSUS ONE DEGLYCOSYLATED RICIN-A CHAINS, Cancer letters, 98(1), 1995, pp. 97-101
Citation: Jk. Kim et al., EVIDENCE THAT THE HINGE REGION PLAYS A ROLE IN MAINTAINING SERUM LEVELS OF THE MURINE IGG1 MOLECULE, Molecular immunology, 32(7), 1995, pp. 467-475
Authors:
SAUSVILLE EA
HEADLEE D
STETLERSTEVENSON M
JAFFE ES
SOLOMON D
FIGG WD
HERDT J
KOPP WC
RAGER H
STEINBERG SM
GHETIE V
SCHINDLER J
UHR J
WITTES RE
VITETTA ES
Citation: Ea. Sausville et al., CONTINUOUS-INFUSION OF THE ANTI-CD22 IMMUNOTOXIN IGG-RFB4-SMPT-DGA INPATIENTS WITH B-CELL LYMPHOMA - A PHASE-I STUDY, Blood, 85(12), 1995, pp. 3457-3465
Citation: Jk. Kim et al., MAPPING THE SITE THAT CONTROLS THE CATABOLISM OF THE MURINE IGG1 MOLECULE BY SITE-DIRECTED MUTAGENESIS, The FASEB journal, 8(4), 1994, pp. 10000467-10000467
Citation: V. Ghetie et al., THE GENERATION OF IMMUNOTOXINS CONTAINING ONE OR 2 TOXIN MOLECULES BOUND TO ANTIBODY, The FASEB journal, 8(4), 1994, pp. 10000505-10000505
Citation: Jk. Kim et al., CATABOLISM OF THE MURINE IGG1 MOLECULE - EVIDENCE THAT BOTH CH2-CH3 DOMAIN INTERFACES ARE REQUIRED FOR PERSISTENCE OF IGG1 IN THE CIRCULATION OF MICE, Scandinavian journal of immunology, 40(4), 1994, pp. 457-465